Summary
CRP levels in 194 serum samples from 43 SLE patients were measured. Patients with inactive disease have levels below 10 μg/ml; patients with active SLE have higher levels, but never over 50 μg/ml. In the presence of infection or inflammatory processes, regardless of the activity of SLE, the levels are significantly higher (p<0.05), and well over 50 μg/ml. Both active SLE patients and inactive SLE patients with local infections have levels between 10 μg/ml and 50 μg/ml. In this situation, the presence of anti-DNA antibodies strongly suggests disease activity (82% versus 9%, p<0.05). The clinical and physiopathological meaning of these findings is discussed.
Similar content being viewed by others
References
Pepys, M.B., C-reactive protein fifty years on. Lancet 1981, 1, 653–656.
Pepys, M.B., Baltz, M.L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 1983, 34, 141–212.
Kushner, I., Gewurz, H., Benson, M.D. C-reactive protein and the acute phase response. J Lab Clin Med 1981, 97, 739–749.
Pepys, M.B. C-reactive protein (CRP), serum amyloid P component (SAP) and serum amyloid A protein (SAA) in autoimmune disease. In: Autoimmunity: Clinics in Immunology and Allergy. Editor: Holborow E.J., WB Saunders Co Ltd, Eastbourne, 1981, 1, 77–101.
Pepys, M.B., Lanham, J.G., De Beer, F.C. C-reactive protein in SLE. Clin Rheum Dis 1982, 8, 91–103.
Becker, G.I., Waldburger, M., Hughes, G.R.V., Pepys, M.B. Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. Ann Rheum Dis 1980, 39, 50–52.
Honing, S., Gorevic, P., Weissmann, G. C-reactive protein in systemic lupus erythematosus. Arthritis Rheum 1977, 20, 1065–70.
Bravo, M.G., Alarcon Segovia, D. C-reactive protein in the differential diagnosis between infection and disease reaction. J Rheumatol 1981, 21, 643–648.
Boey, M.L., Colaco, C.B., Gharavi, A.E., Elkon, K.B., Loizou, S., Hughes, G.R.V. Thrombosis in SLE: Striking association with the presence of circulating lupus anticoagulant. Br Med J 1983, 287, 1021–23.
Bulkley, B.H., Roberts, W.C. The heart in systemic lupus erythematosus and the changes induced in it by corticosteroid therapy. Am J Med 1975, 58, 243–264.
Zizic, T.M., Shulman, L.E., Stevens, M.B. Colonic perforations in systemic lupus erythematosus. Medicine (Baltimore) 1975, 54, 411–426.
Lewis, R.B., Castor, C.W., Knisley, R.E., Bole, G.G. Frequency of neoplasia in systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1976, 19, 1256–1260.
Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rothfield, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.
Liang, M.H., Rogers, M., Larson, M., Eaton, H.M., Murawskibs, B.J., Taylor, J.E., et al. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis. Arthritis Rheum 1984, 27, 13–19.
Hill, A.G.S. C-reactive protein in the chronic rheumatic disease. Lancet 1951, 2, 807–811.
Stahl, N.J., Klippel, J.H., Decker, J.L. Fever in systemic lupus erythematosus. Am J Med 1979, 67, 935–940.
Rordorf, C., Schnebli, H.P., Baltz, M.I., Tennent, G.A., Pepys, M.B. The acute-phase response in (NZB×NZW) Fl and Mrl/l mice. Contrasting patterns resembling those in human systemic lupus erythematosus and rheumatoid arthritis, respectively. J Exp Med 1982, 156, 1268–1273.
Whicher, J.J., Martin, M.F.R., Dieppe, P.A. Absence of prostaglandin stimulated increase in acute phase proteins in systemic sclerosis. Lancet (letter) 1979, 2, 1187–88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Linares, L.F., Gomez-Reino, J.J., Carreira, P.E. et al. C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clin Rheumatol 5, 66–69 (1986). https://doi.org/10.1007/BF02030970
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030970